About this trial
Urinary tract infections (UTIs) are a major clinical issue, especially in pregnant women, due to physiological changes that increase susceptibility. If untreated, UTIs can lead to severe complications like preterm labor and low birth weight. Preeclampsia, a hypertensive disorder affecting 0.2-9.2% of pregnancies, is another leading cause of maternal and fetal complications. The relationship between UTIs and preeclampsia remains controversial, with some studies suggesting an association while others show conflicting results. Research gaps highlight the need for region-specific studies, particularly in Pakistan, where both conditions contribute significantly to maternal and neonatal morbidity.
This study aims to investigate the association between UTIs and preeclampsia in pregnant women in Pakistan. It will use a cohort design, enrolling 160 patients (80 with UTIs, 80 without) from the Obstetrics Department of PAF Hospital, Islamabad. Participants will be followed until delivery, with preeclampsia diagnosed based on blood pressure and proteinuria criteria. Data will be analyzed using SPSS to calculate relative risk (RR), with statistical significance set at RR \>1 and p ≤ 0.05. The findings could help improve prenatal care and reduce adverse outcomes in high-risk populations.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients attending OPD for routine antenatal checkup
Patients diagnosed with UTI as per operational definitions
Gestational age greater than 20 weeks as per LMP
Age between 18 to 35 years
Disqualifiers
Diabetes mellitus
Chronic hypertension
Chronic liver or kidney diseases
Chronic pulmonary conditions
Trial population
Women with gestational amenorrhea coming for routine antenatal checkup
Trial design
Cohort
Prospective
Treatments tested in this trial
Preeclampsia developed
Other interventionPreecalmpsia will be defined as per study protocol
Treatment groups
Trial outcomes
Primary outcomes
Preeclampsia
It will be defined as BP \>140/90 mmHg on minimum two occasions after 20 weeks of pregnancy alongside presence of proteinuria (≥300 mg/day or at least 1+ dipstick testing or spot urine protein/creatinine ratio of ≥30 mg/mmol).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.